Physician profile
Kumar Abhishek
NPI 1083827018
$1,044,344.20
in general payments reported to CMS, 2019-2025
91 companies · $205K in 2025
The $205K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170K · 2020: $47K · 2021: $103K · 2022: $164K · 2023: $121K · 2024: $236K · 2025: $205K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $414K · Consulting Fee: $66K · Travel and Lodging: $61K · Food and Beverage: $15K · Honoraria: $3,260 · Long Term Medical Supply Or Device Loan: $2,250 · Grant: $350 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $414,430.50 |
| Consulting Fee | $66,004.00 |
| Travel and Lodging | $60,527.20 |
| Food and Beverage | $14,655.35 |
| Honoraria | $3,260.00 |
| Long Term Medical Supply Or Device Loan | $2,249.91 |
| Grant | $350.00 |
| Education | $108.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $347,726.60 | 2019-2025 | Imfinzi, Enhertu, Datroway |
| Daiichi Sankyo INC. | $174,923.48 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Amgen INC. | $62,386.53 | 2019-2025 | Kyprolis, Kyprolis, Lumakras |
| Medtronic, INC. | $43,816.25 | 2021-2025 | Intellis Adaptivestim, Osteocool Rf Ablation System |
| Jazz Pharmaceuticals INC. | $42,936.20 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $42,675.45 | 2019-2025 | |
| Glaxosmithkline, LLC. | $41,646.07 | 2021-2025 | Ojjaara, Shingrix |
| Genentech USA, INC. | $39,998.78 | 2019-2023 | Tecentriq, Alecensa, Gavreto |
| Ipsen Biopharmaceuticals, INC | $36,538.98 | 2019-2023 | Tazverik, Onivyde, Somatuline Depot |
| Genzyme Corporation | $28,083.53 | 2019-2025 | |
| Puma Biotechnology, INC. | $20,237.24 | 2019-2023 | Nerlynx |
| Incyte Corporation | $19,529.64 | 2019-2025 | Monjuvi, Jakafi, Monjuvi |
| Bayer Healthcare Pharmaceuticals INC. | $18,879.66 | 2019-2025 | |
| Astellas Pharma US INC | $17,284.36 | 2019-2025 | Vyloy, Padcev, Xospata |
| Stryker Corporation | $16,031.25 | 2019 |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $15,620.05 | 2020-2025 | Xpovio |
| E.R. Squibb & Sons, L.L.C. | $13,554.35 | 2019-2025 | Reblozyl, Opdivo |
| Emd Serono, INC. | $11,063.60 | 2019-2024 | Bavencio |
| Eisai INC. | $9,668.94 | 2019-2023 | |
| Lilly USA, LLC | $6,748.48 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Rigel Pharmaceuticals, INC. | $5,185.51 | 2019-2022 | |
| Verastem, INC. | $3,993.09 | 2019-2020 | |
| Stemline Therapeutics INC. | $3,508.51 | 2023 | Orserdu |
| Regeneron Healthcare Solutions, INC. | $2,719.17 | 2020-2023 | Libtayo |
| Pfizer INC. | $2,248.00 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $2,172.59 | 2019-2024 | Fruzaqla |
| Astellas Pharma Global Development | $1,992.00 | 2021 | |
| Eusa Pharma (US) LLC | $1,846.01 | 2020-2021 | |
| Exelixis INC. | $1,540.71 | 2019-2023 | Cabometyx |
| Janssen Scientific Affairs, LLC | $1,010.00 | 2022 | |
| Astrazeneca Uk Limited | $1,005.00 | 2025 | |
| Life Spine, INC. | $784.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $668.62 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $491.70 | 2019-2023 | Keytruda, Welireg, Lynparza |
| Intuitive Surgical, INC. | $443.46 | 2022 | |
| Cepheid | $425.00 | 2023 | |
| Zimmer Biomet Holdings, INC. | $386.96 | 2019 | |
| Seagen INC. | $361.00 | 2019-2023 | Tukysa, Adcetris |
| Janssen Biotech, INC. | $324.53 | 2019-2023 | Darzalex, Imbruvica |
| Cardinal Health 110 LLC | $275.00 | 2025 | |
| Alexion Pharmaceuticals, INC. | $232.96 | 2019-2023 | Ultomiris |
| Pharmacyclics LLC, An Abbvie Company | $187.19 | 2019-2023 | Imbruvica |
| Bard Peripheral Vascular, INC. | $182.35 | 2022-2024 | Lutonix Drug Coated Balloon |
| Tersera Therapeutics LLC | $173.56 | 2019-2023 | Xermelo, Zoladex |
| Celgene Corporation | $173.06 | 2019-2023 | Pomalyst |
| Abbvie INC. | $169.72 | 2019-2022 | |
| Taiho Oncology, INC. | $169.57 | 2019-2023 | |
| Foundation Medicine, INC. | $157.28 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $148.74 | 2020-2023 | Xarelto |
| Gilead Sciences, INC. | $144.52 | 2019-2023 | Trodelvy |
| Array Biopharma INC | $139.02 | 2019-2023 | Braftovi, Lorbrena, Mektovi |
| Agios Pharmaceuticals, INC. | $94.40 | 2019-2020 | |
| Adaptive Biotechnologies Corporation | $88.83 | 2023-2025 | Clonoseq |
| Dova Pharmaceuticals | $86.83 | 2019-2021 | |
| Novocure INC. | $85.53 | 2024-2025 | Optune Lua (Novottf-200t), Optune |
| Boston Scientific Corporation | $84.98 | 2022-2023 | Therasphere Administration Set, Icefx Cryoablation System |
| Tactile Systems Technology INC | $78.70 | 2020 | |
| Beigene USA, INC. | $76.62 | 2021-2023 | Brukinsa |
| Tempus Ai, INC | $74.52 | 2024-2025 | Xt Cdx |
| Adc Therapeutics America, INC. | $73.40 | 2021-2023 | |
| Caris Mpi, INC. | $71.35 | 2025 | Mi Cancer Seek |
| Pharmacosmos Therapeutics INC. | $61.28 | 2022-2023 | Monoferric |
| Kite Pharma, INC. | $54.09 | 2022 | |
| Coherus Oncology, INC. | $51.31 | 2023 | |
| Inari Medical, INC. | $49.44 | 2020 | |
| Sumitomo Pharma America, INC. | $48.30 | 2023 | Orgovyx |
| Amag Pharmaceuticals, INC. | $46.62 | 2019-2020 | |
| Clovis Oncology, INC. | $45.58 | 2019-2021 | |
| G1 Therapeutics, INC. | $38.94 | 2022-2023 | Cosela |
| Genentech, INC. | $37.37 | 2024-2025 | Polivy, Lunsumio, Venclexta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.10 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $35.05 | 2021 | |
| Blue Earth Diagnostics | $32.26 | 2021-2023 | |
| Mylan Institutional INC. | $30.36 | 2023 | Ogivri, Fulphila |
| Geron Corporation | $30.32 | 2025 | Rytelo |
| Pharmaessentia USA Corporation | $29.91 | 2022 | |
| Kyowa Kirin, INC. | $29.11 | 2019 | |
| Mirati Therapeutics, INC. | $27.22 | 2023 | Krazati |
| Microvention, INC. | $25.28 | 2025 | Sofia 6f-131cm Str |
| Tg Therapeutics, INC. | $24.82 | 2022 | |
| Sobi, INC | $22.63 | 2023 | |
| Myovant Sciences INC. | $20.04 | 2021 | |
| Medtronic USA, INC. | $19.47 | 2019 | |
| Immunocore Limited | $17.98 | 2023 | Kimmtrak |
| Inogen, INC. | $16.19 | 2022 | |
| Morphosys, US INC. | $15.96 | 2022 | |
| Sirtex Medical INC | $15.92 | 2020 | |
| Acrotech Biopharma INC. | $15.25 | 2022 | |
| Aveo Pharmaceuticals, INC. | $15.18 | 2022 | |
| Acceleron Pharma, INC. | $14.95 | 2021 | |
| Allergan, INC. | $14.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kumar Abhishek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.